
John Harrison Krystal MD
Addiction
Robert L. McNeil, Jr. Professor of Psychiatry and Professor of Neuroscience; Chair, Department of Psychiatry; Chief of Psychiatry, Yale-New Haven Hospital; Director: NIAAA Center for the Translational Neuroscience of Alcoholism ; Director, Clinical Neuroscience Division, VA National Center for PTSD (VA Connecticut); Co-Director, Yale Center for Clinical Investigation, Yale University
Join to view full profile
300 George St. #901New Haven, CT 06511
Phone+1 203-785-6396
Fax+1 203-785-6196
Dr. Krystal is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Krystal is the Robert L. McNeil, Jr., Professor and Chair of the Yale Department of Psychiatry and Psychiatrist-in-Chief of the Yale-New Haven Health System. A graduate of the Yale School of Medicine and the Yale Psychiatry Residency, he studies the neurobiology and treatment of psychiatric disorders. His laboratory discovered the rapid antidepressant effects of ketamine, leading to the FDA approval of Spravato. He directs/co-directs the Yale Center for Clinical Investigation (CTSA), Center for the Translational Neuroscience of Alcohol (NIAAA), and Neuroscience Division of the National Center for PTSD (VA). He is a member of the National Academy of Medicine and recipient of its Sarnat Prize; Fellow of the American Association for the Advancement of Science; editor of Biological Psychiatry; co-founder of Freedom Biosciences; Board of Directors Member of the Clinical Research Forum; and Vice President of the Scientific Council of the Brain and Behavior Foundation. He is based in New Haven, CT.
Education & Training
Yale-New Haven Medical CenterResidency, Psychiatry, 1985 - 1988
Yale-New Haven Medical CenterInternship, Transitional Year, 1984 - 1985
Yale School of MedicineClass of 1984
Certifications & Licensure
CT State Medical License 1986 - 2027
American Board of Psychiatry and Neurology Psychiatry
Awards, Honors, & Recognition
- Rhoda and Bernard Sarnat International Prize in Mental Health National Academy of Medicine, 2023
- Elected Member Institute of Medicine, 2010
Clinical Trials
Publications & Presentations
PubMed
- Direct and indirect associations linking COVID-19 severity to internalizing disorders and symptoms among participants in New Haven, CT.David Davtian, Dan Qiu, Brenda Cabrera-Mendoza, Yaira Z Nunez, John H Krystal
Journal of Affective Disorders. 2026-11-01 - 1 citationsChildhood Maltreatment and Deviations From Normative Brain Structure: A Mega-Analysis of 3711 Individuals From the ENIGMA Major Depressive Disorder and ENIGMA Posttrau...Haley R Wang, Zhen-Qi Liu, Elena Pozzi, Ahmed Hussain, Priyanka Sigar
Biological Psychiatry. 2026-09-15 - Reversible alterations of brain acetate metabolism associated with alcohol consumption.Chathura Kumaragamage, Lihong Jiang, Gustavo A Angarita, Robin A de Graaf, Elizabeth Guidone
Neuropsychopharmacology. 2026-09-01
Journal Articles
- Association of Ketamine with Psychiatric Symptoms and Implications for Its Therapeutic Use and for Understanding SchizophreniaMohini Ranganathan, John H Krystal, JAMA Network Open
- A Multicenter Study of Ketamine Effects on Functional Connectivity: Large Scale Network Relationships, Hubs and Symptom MechanismsRagy R Girgis, Richard J Maddock, John D Ragland, Daniel C Javitt, Cameron S Carter, Joshua T Kantrowitz, Jeffrey Lieberman, John H Krystal, Lawrence S Kegeles, Willia..., ScienceDirect
- Celebrating 50 Years of Biological Psychiatry: To the Future, and BeyondJohn Krystal, MD, Biological Psychiatry
Authored Content
- Characteristics of Ongoing Clinical Trials for Alcohol Use Disorder Registered on ClinicalTrials.govMay 2020
- Characteristics of Ongoing Clinical Trials for Alcohol Use Disorder Registered on ClinicalTrials.govMay 2020
- F131. Genome-Wide Association Study Identifies Glutamate Ionotropic Receptor GRIA4 as a Risk Gene for Comorbid Nicotine Dependence and Major DepressionApril 2018
Press Mentions
Krystal Awarded 2026 Connecticut Medal of TechnologyMay 18th, 2026
Pietrzak to Receive 2026 ISTSS Laufer Memorial Award for Outstanding Scientific AchievementMay 6th, 2026
In Memoriam: Robert Jay Lifton, MDSeptember 8th, 2025
Grant Support
- AMPA Receptor Components of the Antidepressant Response to Ketamine in HumansYALE UNIVERSITY2023–2028
- Yale Clinical and Translational Science Award (U Component)YALE UNIVERSITY2026–2027
- Yale Clinical and Translational Science Award (U Component)YALE UNIVERSITY2026–2027
- Center for the Translational Neuroscience of AlcoholismYALE UNIVERSITY2001–2026
- Center for the Translational Neuroscience of AlcoholismYALE UNIVERSITY2001–2026
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:









